848693433	848693433	CD	B-NP	O
|	|	NN	I-NP	O
FMIH	FMIH	NN	I-NP	O
|	|	NN	I-NP	O
85780676	85780676	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8654440	8654440	CD	B-NP	O
|	|	CC	I-NP	O
5/24/2006	5/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/3/2006	8/3/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2006	8/13/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
KAPPLER	KAPPLER	NN	B-NP	O
,	,	,	O	O
TRINIDAD	TRINIDAD	NNP	B-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
9-day	9-day	JJ	I-NP	O
admission	admission	NN	I-NP	O
from	from	IN	B-PP	O
6/10/2006	6/10/2006	CD	B-NP	O
to	to	TO	B-PP	O
05	05	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
NSCHC	NSCHC	NNP	B-NP	B-cell_type
Cardiology	Cardiology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
1/16/2006	1/16/2006	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
15	15	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
2500	2500	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
assessment	assessment	NN	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
under	under	IN	B-PP	O
diuresed	diurese	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
directly	directly	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Poredtiesbarre	Poredtiesbarre	NNP	B-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
reinitiation	reinitiation	NN	B-NP	O
of	of	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
to	to	TO	B-PP	O
torsemide	torsemide	NN	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
endorsed	endorse	VBD	B-VP	O
worsened	worsen	VBN	I-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
early	early	JJ	B-NP	O
satiety	satiety	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalents	equivalent	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ischemic	Ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-35	-35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
newly	newly	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
tibial	tibial	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
and	and	CC	O	O
fem-pop	fem-pop	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Glaucoma	Glaucoma	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
with	with	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Osteoarthritis	Osteoarthritis	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
SVMC	SVMC	NNP	B-NP	O
Renal	Renal	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
18	18	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
nightly	nightly	RB	B-ADVP	O
6	6	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Procrit	Procrit	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	B-protein
sublingual	sublingual	JJ	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
injections	injection	NNS	I-NP	O
at	at	IN	B-PP	O
clinic	clinic	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
and	and	CC	O	O
nonsteroidal	nonsteroidal	JJ	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
quit	quit	VBD	B-VP	O
tobacco	tobacco	NN	B-NP	O
with	with	IN	B-PP	O
rare	rare	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
was	be	VBD	B-VP	O
98.9	98.9	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
104/50	104/50	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
15	15	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
with	with	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
dullness	dullness	NN	I-NP	O
well	well	RB	B-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nonpulsatile	nonpulsatile	JJ	I-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hips	hip	NNS	I-NP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
and	and	CC	I-NP	O
venous	venous	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Laboratory	Laboratory	NN	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
11.7	11.7	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
27.9	27.9	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
repolarization	repolarization	NN	I-NP	O
,	,	,	I-NP	O
ST	ST	NN	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
vascular	vascular	JJ	I-NP	O
markings	marking	NNS	I-NP	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
fissure	fissure	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
infiltrates	infiltrate	NNS	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
insufficient	insufficient	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
pump	pump	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
clearly	clearly	RB	B-ADVP	O
in	in	IN	B-PP	O
gross	gross	JJ	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
from	from	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
sided	sided	JJ	I-NP	O
and	and	CC	I-NP	O
left-sided	left-sided	JJ	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
severely	severely	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
or/and	or/and	NN	I-NP	O
organ	organ	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
and	and	CC	O	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
decompensated	decompensate	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADJP	O
overnight	overnight	JJ	I-ADJP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
tapered	taper	VBD	B-VP	O
off	off	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
turned	turn	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	B-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-VP	O
b.i.d.	b.i.d.	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
met	meet	VBD	B-VP	O
her	her	PRP$	B-NP	B-DNA
I	I	NNP	I-NP	I-DNA
&	&	CC	I-NP	I-DNA
O	O	NNP	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
overnight	overnight	RB	B-ADVP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Diuril	Diuril	NNP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
little	little	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
insufficient	insufficient	JJ	B-ADJP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
to	to	TO	B-PP	O
Diuril	Diuril	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
from	from	IN	B-PP	O
2.9	2.9	CD	B-NP	O
.	.	.	O	O

gradually	gradually	RB	B-ADVP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
good	good	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
without	without	IN	B-PP	O
bump	bump	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/25/2006	4/25/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
greatly	greatly	RB	I-VP	O
improved	improve	VBN	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
improved	improve	VBN	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
met	meet	VBN	I-VP	O
her	her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
85	85	CD	I-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
on	on	IN	B-PP	O
4/25/2006	4/25/2006	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
for	for	IN	B-PP	O
anticipated	anticipated	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
8/13/2006	8/13/2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Diuril	Diuril	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
anticipated	anticipate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
b.i.d.	b.i.d.	NN	B-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	I-NP	O
p.o.	p.o.	NN	I-NP	O
on	on	IN	B-PP	O
metolazone	metolazone	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
new	new	JJ	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
at	at	IN	B-PP	O
85	85	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
should	should	MD	O	O
she	she	PRP	B-NP	O
require	require	VB	B-VP	O
admission	admission	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
CSH	CSH	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
being	be	VBG	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
eventually	eventually	RB	B-ADVP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
off	off	RP	B-PRT	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
recheck	recheck	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	O	O
restart	restart	VB	B-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
falls	fall	VBZ	B-VP	O
below	below	IN	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

Denied	Deny	VBN	B-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
did	do	VBD	B-VP	O
increase	increase	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
renally-dosed	renally-dosed	JJ	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
actually	actually	RB	B-VP	O
required	require	VBD	I-VP	O
repletion	repletion	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
despite	despite	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
LCH	LCH	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
whom	whom	WP	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
conversations	conversation	NNS	I-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
them	them	PRP	B-NP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
:	:	:	O	O
3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
all	all	DT	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
either	either	CC	B-PP	O
on	on	IN	B-PP	O
imaging	imaging	NN	B-NP	O
or	or	CC	B-PP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
picture	picture	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
exam	exam	NN	I-NP	O
both	both	DT	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
erratic	erratic	JJ	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
p.m.	p.m.	NN	I-NP	O
Lantus	Lantus	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
18	18	CD	B-NP	O
units	unit	NNS	I-NP	O
to	to	TO	B-PP	O
16	16	CD	B-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/10/2006	11/10/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
lower	low	JJR	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
routinely	routinely	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
q.a.c.	q.a.c.	NNP	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
1	1	CD	B-NP	O
morning	morning	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
fingerstick	fingerstick	JJ	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
hypothermic	hypothermic	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
94	94	CD	B-NP	O
taken	take	VBN	B-VP	O
rectally	rectally	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
progressed	progress	VBN	I-VP	O
over	over	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
assessment	assessment	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
at	at	IN	B-PP	O
98	98	CD	B-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
repleted	replete	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
likely	likely	RB	B-ADJP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
metabolism	metabolism	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
injected	inject	VBN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Lantus	Lantus	NNP	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
curbside	curbside	NN	I-NP	O
consultation	consultation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
simply	simply	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
Lantus	Lantus	NNP	I-NP	O
dose	dose	NN	I-NP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
hesitant	hesitant	JJ	B-ADJP	O
to	to	TO	B-VP	O
change	change	VB	I-VP	O
the	the	DT	B-NP	O
types	type	NNS	I-NP	O
or	or	CC	I-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
left	leave	VBD	B-VP	O
that	that	IN	B-SBAR	O
item	item	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
further	further	RBR	B-ADJP	O
managed	manage	VBN	I-ADJP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
.	.	.	O	O

Hematologic	Hematologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
normocytic	normocytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
felt	feel	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Aranesp	Aranesp	NN	B-NP	O
through	through	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Procrit	Procrit	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
with	with	IN	B-PP	O
further	further	JJ	B-NP	O
discussion	discussion	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GGVH	GGVH	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
fluid	fluid	JJ	B-ADJP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
home	home	NN	I-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Bublitz	Bublitz	NNP	I-NP	O
at	at	IN	B-PP	O
MHS	MHS	NN	B-NP	B-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
SRRH	SRRH	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
and	and	CC	O	O
Renal	Renal	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
within	within	IN	B-PP	O
4-5	4-5	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
restarted	restart	VBD	B-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2.5	2.5	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lantus	Lantus	NN	B-NP	O
insulin	insulin	NN	I-NP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Metolazone	Metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
fluid	fluid	NN	B-NP	O
retention	retention	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Procrit	Procrit	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-4726233	4-4726233	CD	B-NP	O
RFFocus	RFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BURROW	BURROW	NNP	B-NP	O
,	,	,	O	O
KENNETH	KENNETH	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NOVAKOVICH	NOVAKOVICH	NNP	B-NP	O
,	,	,	O	O
CURT	CURT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7589237	7589237	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/5/06	6/5/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/7/06	4/7/06	CD	B-NP	O

